INTRODUCTION: Intravenous Chelation therapy is a medical treatment used for cardiovascular heart disease by improving metabolic and circulatory function by removing toxic metals such as Lead, Cadmium, Arsenic, Aluminum, Uranium, and abnormally located nutritional metallic ions such as copper and iron from the body. Heavy metals contribute to plaque in the arteries, loss of memory function; adversely affect vital organs such as the liver, thyroid, parathyroid, and heart. It can depress immune systems as well as brain function. What is IV Chelation therapy? This is a therapy administered by an intravenous infusion of a synthetic amino acid, ethylene-diamine-tetra-acetic acid (EDTA). In Dr. Elmer Cranton, M.D.’s book "Bypassing Bypass Surgery" he states many reasons for Chelation intravenous (IV) therapy. EDTA controls free radical damage that destroys cells as it removes heavy metals, restoring normal enzyme functioning. EDTA controls oxidative damage to cell membranes and enhances the efficiency of energy metabolism, independent of any effect on blood flow or oxygen. The intravenous therapy removes excess metal ions, redistributes abnormally high concentrations of essential nutritional trace elements in blood-deprived tissues, helps reestablish prostaglandin hormone balance which reduces arterial spasm, blood clots, plaque formation and arthritis; protects the integrity of blood platelets, normalizes calcium metabolism, intermittently lowers serum calcium by stimulating uptake of calcium in bones, increases tissue flexibility and encourages overall metabolic efficiency due to the whole range of above mentioned factors.
Oral or rectal Chelation therapy with EDTA, even in small doses, can bind to other nutrients and trace minerals preventing absorption thereby detrimental to health. The only safe way to administer EDTA is intravenously. In "A Textbook on EDTA Chelation Therapy" by Elmer M. Cranton, M.D., he states "Marketing companies have been targeting the public with mass mailings and advertisements for so-called oral chelation—selling nutritional supplements containing EDTA, while deceptively using data from studies of intravenous EDTA to support such products. Recently that practice spread to the aggressive marketing of EDTA as a rectal suppository. In my opinion, those practices are deceptive and potentially dangerous. No statistically significant scientific evidence for effectiveness exists. EDTA is poorly absorbed by either the oral or rectal route. All statistically significant published data for effectiveness applies only to intravenous EDTA. DMSA, a chelating drug that is well absorbed orally, does not have the beneficial effect of intravenous EDTA on atherosclerosis and diseases of aging."
back to top
HISTORY of EDTA: In 1893 Swiss Nobel laureate Alfred Werner developed the concept on how metals bind to organic molecules. In the early 1920’s chelation found a wide application in the manufacture of paint, rubber and petroleum. It was also found useful in the separation of specific metals. It gained importance in electroplating and industrial dye manufacture. In the mid 1930’s German scientists developed EDTA or ethylene-diamine-tetra-acetate in working to develop a synthetic calcium-binding additive to keep stains from forming when calcium in hard water reacted with certain dyes. Since then EDTA synthesis has been refined and accepted by the FDA in the United States as a chelate for toxic heavy metals. EDTA as a chelate is used today in hundreds of everyday products. Not until World War II were the potential therapeutic benefits of Chelation realized as a treatment for arsenic and lead as well as other heavy metals. In his book "Bypassing Bypass Surgery" Elmer Cranton MD states that in the 1950’s "A group of workers suffering lead poisoning in a battery factory in Michigan were successfully detoxified." And, "Next, the U.S. Navy adopted EDTA Chelation therapy for sailors who were poisoned by absorbing lead while painting ships at other naval facilities. By the mid-1950’s, it was becoming the accepted ‘treatment of choice’ for lead poisoning in children and adults and, as of today, it still is." He also states that, "EDTA Chelation therapy was first used to treat cardiovascular disease by an eminent cardiologist and chief of research at the Providence Hospital in Detroit, Michigan." From there it developed into a society of doctors that is now known as American College of Advancement in Medicine or ACAM.
EDTA, besides removing heavy metals has many health benefits. A study from Japan found that EDTA given intravenously into mice increased the blood concentration of interferon four to twelve fold. Interferon is produced by the immune system and increases immunity. EDTA restricts free radical proliferation and allows the body’s natural antioxidant defenses to regain control.
back to top
SAFETY: Hundreds of thousands of people have now undergone Chelation
therapy and thousands of scientific articles have been written about
the process. Chelation therapy is not only safer than the
conventional methods of treating ailments of cardiovascular disease such as blocked arteries from
plaque formation, but also strengthens bones by increasing their
calcium uptake, providing an indirect treatment for osteoporosis.
Surgery often addresses the symptoms of a disease, while Chelation
therapy goes directly to its causes and reverses the damaging
processes. People who are prone to strokes often have poor cerebral
circulation, according to one large study. Chelation therapy can
help prevent a stroke or lessen its effects by removing calcium and
other mineral deposits from the arteries in the neck and head,
helping to improve the blood flow. A study of 19,000 people with
peripheral vascular disease showed 82.5% of those who received
Chelation therapy showed substantial improvement. Diabetes also
responds well because the disease also involves the arteries. It
also may decrease the need for more insulin by opening up the
insulin receptors. Chelation can be used in treatment of many other
diseases as Autism, Parkinson’s, ALS, Alzheimer’s, dementia, macular
degeneration, hypertension, arthritis, scleroderma, multiple
sclerosis, and high cholesterol.
Other documented benefits* of chelation therapy include:
* see our website page "Articles" for medical journal references
According to Dr. Elmer Cranton, M.D., chelation therapy has a profound effect on overall health. To some extent it slows the aging process. Chemical sensitivities and allergies also seem to improve due to a better functioning of the immune system. Also, all types of arthritis and muscle and joint aches and pains seem to improve after chelation. In most cases, progression of Alzheimer’s disease will be slowed and in some cases the improvement being quite remarkable. Macular degeneration, a major cause of visual loss in the elderly, is often improved and almost always arrested or slowed by chelation therapy. Dr. Raymond Psonak, D.O., of New Gloucester, Maine also concurs he has seen marked improvements with intravenous EDTA in cardiovascular disease.
back to top
Chelation therapy using EDTA as a chelate is a relatively inexpensive, safe and
effective technique for medical management of cardiovascular disease and
related diseases. If you are interested, just give us a call at 207-657-4325; we
will be happy to answer all of your questions.
back to top